The first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

Significant year-to-year fluctuations in cholesterol levels without changes in medication may indicate that older adults have a higher risk for cognitive decline or dementia, according to preliminary ...

A new study by Monash University medicine safety experts found the use of gabapentinoids – medicines widely used to treat neuropathic pain – increased the risk of hip fractures, especially in older ...

Older adults whose cholesterol levels fluctuate from year to year may face an increased risk for dementia and cognitive decline compared to people whose cholesterol levels remain more stable, new ...

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.